Spikevax JN.1 Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

White to off white dispersion (pH: 7.1 - 7.8).
Spikevax JN.1 qualitative and quantitative composition: See Table 1.

Click on icon to see table/diagram/image

SARS-CoV-2 JN.1 mRNA is a single-stranded, 5'-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2 (JN.1).
Excipients/Inactive Ingredients: SM-102 (heptadecan-9-yl 8-{(2-hydroxyethyl)[6-oxo-6-(undecyloxy)hexyl]amino}octanoate); Cholesterol; 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC); Polyethylene glycol 2000 dimyristoyl glycerol (PEG2000-DMG); Trometamol; Trometamol hydrochloride; Acetic acid; Sodium acetate trihydrate; Sucrose; Water for injections.

Manufacturer:

Moderna

Distributor:

Zuellig